CDC Continues To Work With Global Partners To Eliminate Hepatitis B

CDC’s “Our Global Voices”: Vaccination remains the most cost-effective strategy to get on track with hepatitis B elimination in resource-limited settings
Rania Tohme, team lead at the CDC’s Global Immunization Division, discusses global efforts to address hepatitis B and the challenges facing vaccine accessibility and delivery in resource-limited settings. “At the moment, the most cost-effective approach in resource-limited settings is provision of the hepatitis B vaccine birth dose followed by 2-3 additional doses of pentavalent vaccine. … [M]ore efforts are needed to promote hepatitis B vaccine birth dose introduction and increase vaccination in Africa and Asia. CDC’s commitment to collaborating with global partners to eliminate hepatitis B will continue to contribute to the impact of hepatitis B vaccination,” she writes (7/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.